Literature DB >> 11323178

The use of gene knockout mice to unravel the mechanisms of toxicity and chemical carcinogenesis.

F J Gonzalez1.   

Abstract

Metabolism of toxins and carcinogens is carried out by large groups of xenobiotic-metabolizing enzymes. These enzymes are generally considered to be required for elimination of xenobiotics such as drugs, dietary chemicals and environmental pollutants, and to be required for chemical toxicity and carcinogenicity. An important role for these enzymes in metabolism of endogenous chemicals has not been established. Mouse lines in which the genes encoding several xenobiotic-metabolizing enzymes were knocked out were produced and are being used to determine the role of metabolism in carcinogenesis, and acute and chronic toxicities in vivo. Mouse lines lacking the P450s CYP1A1, CYP1A2, CYP1B1 and CYP2E1, microsomal epoxide hydrolase (mEH), NADPH:quinone oxidoreductase and the glutathione S-transferase P1 have no deleterious phenotypes, indicating that these enzymes are not required for mammalian development and physiological homeostasis. However, when challenged with toxins and carcinogens, they respond differently from their wild-type (WT) counterparts. For example, mice lacking CYP1A2 and CYP2E1 are totally resistant to acetaminophen-induced hepatotoxicity. Mice lacking CYP1B1 or mEH are less responsive to tumorigenesis by 7,12-dimethybenz[a]anthracene. However, CYP1A2-null mice do not significantly differ from WT mice in their response to the hepatocarcinogen 4-aminobiphenyl. These and other studies indicate that the xenobiotic-metabolism null mice are of great value in the study of the mechanisms of chemical injury.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11323178     DOI: 10.1016/s0378-4274(01)00296-x

Source DB:  PubMed          Journal:  Toxicol Lett        ISSN: 0378-4274            Impact factor:   4.372


  13 in total

1.  Mouse lung CYP1A1 catalyzes the metabolic activation of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP).

Authors:  Xiaochao Ma; Jeffrey R Idle; Michael A Malfatti; Kristopher W Krausz; Daniel W Nebert; Chong-Sheng Chen; James S Felton; David J Waxman; Frank J Gonzalez
Journal:  Carcinogenesis       Date:  2006-10-19       Impact factor: 4.944

Review 2.  Chemically induced carcinogenesis in rodent models of aging: assessing organismal resilience to genotoxic stressors in geroscience research.

Authors:  Anna Csiszar; Priya Balasubramanian; Stefano Tarantini; Andriy Yabluchanskiy; Xin A Zhang; Zsolt Springo; Doris Benbrook; William E Sonntag; Zoltan Ungvari
Journal:  Geroscience       Date:  2019-04-29       Impact factor: 7.713

3.  Striking LD50 variation associated with fluctuations of CYP2E1-positive cells in hepatic lobule during chronic CCl4 exposure in mice.

Authors:  Hiroshi Irie; Anshin Asano-Hoshino; Yoshihisa Sekino; Makoto Nogami; Tomoyuki Kitagawa; Hiroaki Kanda
Journal:  Virchows Arch       Date:  2010-02-13       Impact factor: 4.064

4.  7,12-dimethylbenz[a]anthracene induces sertoli-leydig-cell tumors in the follicle-depleted ovaries of mice treated with 4-vinylcyclohexene diepoxide.

Authors:  Zelieann R Craig; John R Davis; Samuel L Marion; Jennifer K Barton; Patricia B Hoyer
Journal:  Comp Med       Date:  2010-02       Impact factor: 0.982

5.  Orofacial cleft risk is increased with maternal smoking and specific detoxification-gene variants.

Authors:  Min Shi; Kaare Christensen; Clarice R Weinberg; Paul Romitti; Lise Bathum; Anthony Lozada; Richard W Morris; Michael Lovett; Jeffrey C Murray
Journal:  Am J Hum Genet       Date:  2006-12-07       Impact factor: 11.025

6.  Red meat intake, doneness, polymorphisms in genes that encode carcinogen-metabolizing enzymes, and colorectal cancer risk.

Authors:  Michelle Cotterchio; Beatrice A Boucher; Michael Manno; Steven Gallinger; Allan B Okey; Patricia A Harper
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-11       Impact factor: 4.254

7.  Pretreatment with black tea polyphenols modulates xenobiotic-metabolizing enzymes in an experimental oral carcinogenesis model.

Authors:  P Vidjaya Letchoumy; K V P Chandra Mohan; J J Stegeman; H V Gelboin; Y Hara; S Nagini
Journal:  Oncol Res       Date:  2008       Impact factor: 5.574

Review 8.  The use of genetically modified mice in cancer risk assessment: challenges and limitations.

Authors:  David A Eastmond; Suryanarayana V Vulimiri; John E French; Babasaheb Sonawane
Journal:  Crit Rev Toxicol       Date:  2013-09       Impact factor: 5.635

Review 9.  Targeting cytochrome P450 enzymes: a new approach in anti-cancer drug development.

Authors:  Robert D Bruno; Vincent C O Njar
Journal:  Bioorg Med Chem       Date:  2007-05-23       Impact factor: 3.641

Review 10.  Insights on cytochrome p450 enzymes and inhibitors obtained through QSAR studies.

Authors:  Jayalakshmi Sridhar; Jiawang Liu; Maryam Foroozesh; Cheryl L Klein Stevens
Journal:  Molecules       Date:  2012-08-03       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.